COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,942 Articles (22,604 medRxiv, 8,338 bioRxiv)

Most recent first Previous |  Page 1192: Articles 11911-11920  | Next

A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
Higdon, M. M., Wahl, B., Jones, C. B., Rosen, J. G., Truelove, S. A., Baidya, A., Nande, A. A., ShamaeiZadeh, P. A., Walter, K. K., Feikin, D. R., Patel, M. K., Deloria Knoll, M., Hill, A. L.
10.1101/2021.09.17.21263549 — Posted: 2021-09-25
LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
Shilts, J., Crozier, T. M., Teixeira-Silva, A., Gabaev, I., Greenwood, E. J. D., Watson, S. J., Ortmann, B. M., Gawden-Bone, C. M., Pauzaite, T., Hoffmann, M., Nathan, J. A., Pöhlmann, S., Lehner, P. J., Wright, G. J.
10.1101/2021.09.25.461776 — Posted: 2021-09-25
Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and thrombosis
Eltobgy, M., Zani, A., Kenney, A., Estfanous, S., Kim, E., Badr, A., Carafice, C., Daily, K., Whitham, O., Pietrzak, M., Webb, A., Kawahara, J., Eddy, A., Denz, P., Lu, M., KC, M., Peeples, M., Li, J., Zhu, J., Que, J., Robinson, R., Rosas Mejia, O., Rayner, R., Hall-Stoodley, L., Seveau, S., Gavrilin, M. A., Tedeschi, A., Partida-Sanchez, S., Roberto, F., Hemann, E., Abdelrazik, E., Forero, A., Nimjee, S., Boyaka, P., Cormet-Boyaka, E., Yount, J., Amer, A.
10.1101/2021.09.24.461743 — Posted: 2021-09-25
LIGHTHOUSE illuminates therapeutics for a variety of diseases including COVID-19
Shimizu, H., Kodama, M., Matsumoto, M., Orba, Y., Sasaki, M., Sato, A., Sawa, H., Nakayama, K. I.
10.1101/2021.09.25.461785 — Posted: 2021-09-25
Screening key genes and signaling pathways in COVID-19 infection and its associated complications by integrated bioinformatics analysis
Vastrad, B. M., Vastrad, C. M.
10.1101/2021.09.24.461631 — Posted: 2021-09-25
Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD
Ma, H., Guo, Y., Tang, H., Tseng, C.-T., Wang, L., Zong, H., Wang, Z., He, Y., Chang, Y., Wang, S., Huang, H., Ke, Y., Yuan, Y., Wu, M., Zhang, Y., Drelich, A., Kempaiah, K., Peng, B.-H., Wang, A., Yang, K., Yin, H., Liu, J., Yue, Y., Xu, W., Zhu, S., Ji, T., Zhang, X., Wang, Z., Li, G., Liu, G., Song, J., Mu, L., Xiang, Z., Song, Z., Chen, H., Bian, Y., Zhang, B., Chen, H., Zhang, J., Liao, Y., Zhang, L., Yang, L., Chen, Y., Gilly, J., Xiao, X., Han, L., Jiang, H., Xie, Y., Zhou, Q., Zhu, J.
10.1101/2021.09.24.461616 — Posted: 2021-09-25
Comparison of adverse events between COVID-19 and Flu vaccines
Pradhan, P. M., Li, C., Shen, Z., Remucal, M. J.
10.1101/2021.09.22.21263711 — Posted: 2021-09-25 Discussion: Offsite
Covid-19 Per Capita Fatality Rate: A Path Analysis Model
Penuliar, M. S., Clark, C., Curti, D., Carrasco, M., Hudson, C., Philips, B.
10.1101/2021.09.22.21263976 — Posted: 2021-09-25
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication by targeting its major protease in a non-competitive way
Chaves, O. A., Sacramento, C. Q., Fintelman-Rodrigues, N., Temerozo, J. R., Pereira-Dutra, F., Mizurini, D. M., Monteiro, R. Q., Vazquez, L., Bozza, P. T., Castro-Faria-Neto, H. C., Souza, T. M. L.
10.1101/2021.09.23.461605 — Posted: 2021-09-24
High-throughput super-resolution analysis of influenza virus pleomorphism reveals insights into viral spatial organization
McMahon, A., Andrews, R., Ghani, S. V., Cordes, T., Kapanidis, A. N., Robb, N. C.
10.1101/2021.09.23.461536 — Posted: 2021-09-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).